z-logo
open-access-imgOpen Access
Preimplantation Genetic Testing for Aneuploidy Improves Clinical, Gestational, and Neonatal Outcomes in Advanced Maternal Age Patients Without Compromising Cumulative Live-Birth Rate.
Author(s) -
Laura Sacchi,
Elena Albani,
Amalia Cesana,
Antonella Smeraldi,
Valentina Parini,
Marco Fabiani,
Maurizio Poli,
Antonio Capalbo,
Paolo Emanuele Levi-Setti
Publication year - 2019
Publication title -
journal of assisted reproduction and genetics
Language(s) - English
Resource type - Journals
eISSN - 1573-7330
pISSN - 1058-0468
DOI - 10.1007/s10815-019-01609-4
Subject(s) - aneuploidy , pregnancy , reproductive medicine , medicine , live birth , obstetrics , embryo transfer , gestational age , premature birth , miscarriage , gestation , pregnancy rate , gynecology , advanced maternal age , genetic testing , fetus , biology , genetics , gene , chromosome
To report the effects of blastocyst stage aneuploidy testing on clinical, gestational, and neonatal outcomes for patients of advanced maternal age undergoing IVF.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here